Platinum Sponsor
Glaukos
Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm.
Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012 and launched its next-generation iStent inject® device in the United States in September 2018.
In corneal health, Glaukos’ proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions.
Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
Gold Sponsor
h-Trak
Hospitals performing ophthalmic surgery are highly dependent on efficient and transparent processes to treat a high number of patients while maintaining highest clinical standards. h-trak provides a solution to simplify and automate the tasks for inventory, purchasing, billing, and reporting.
h-trak does this by providing a patient-centric inventory management solution designed from the ground up for the unique requirements of ophthalmic surgery, including consignment stock management, lenses being brought in by sales reps and lenses for specific patients. The system includes an integrated preference card management system, inventory, purchasing and cost reporting management functions.
Silver Sponsor
bnz
At the Bank of New Zealand we know that the healthcare of New Zealanders plays a vital role in the future growth of New Zealand. BNZ has specialist healthcare sector bankers who bring their insights, connections and financial expertise to the sector and it’s people.
Bronze Sponsor
Legacy Benefits
After years of professional training to become a qualified specialist its vital that Ophthalmologists get the right advice to protect their future income potential. Let Legacy help evaluate the best options for you.
Legacy would like to offer a free, no obligation, review of your insurance needs - business and professional.
Please see our website for details of our services: http://www.legacygroup.co.nz/ and contact Simon Rupapera for a confidential discussion - DDI 09 354 5500,
M 021 895 114 E simon.rupapera@legacygroup.co.nz
Medix 21
Medix 21 is a New Zealand-owned leading supplier of quality, innovative and cost-effective ophthalmology products and solutions. Our patient-centric team delivers excellent service and honest advice, backed by strong clinical and technical expertise. Collaborating with clinicians and healthcare professionals we are committed to improving quality of life.
Zeiss
The Carl Zeiss Group operates worldwide in the optical and opto-electronic industries. Headquartered in Oberkochen, Germany, Carl Zeiss is represented in more than 30 countries, with 30 production sites around the world. ZEISS has pioneered many ground-breaking technologies in ophthalmology and is constantly seeking to develop innovative solutions for both the clinic and theatre.
Supporters
Past Sponsors
